John H Kempen

Author PubWeight™ 66.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Surgical strategies for coexisting glaucoma and cataract: an evidence-based update. Ophthalmology 2002 2.45
2 Uveitis in patients with autoimmune hepatitis. Am J Ophthalmol 2009 2.02
3 Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology 2011 2.00
4 The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol 2010 1.83
5 Cyclosporine for ocular inflammatory diseases. Ophthalmology 2010 1.75
6 The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med 2005 1.75
7 Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology 2007 1.68
8 Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol 2010 1.61
9 Methotrexate for ocular inflammatory diseases. Ophthalmology 2009 1.58
10 The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol 2004 1.52
11 Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol 2007 1.50
12 Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002 1.48
13 Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005 1.46
14 Azathioprine for ocular inflammatory diseases. Am J Ophthalmol 2009 1.44
15 Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol 2009 1.41
16 Birdshot retinochoroidopathy: ocular complications and visual impairment. Am J Ophthalmol 2005 1.31
17 Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 2007 1.24
18 Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol 2008 1.23
19 Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 2005 1.22
20 Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. Ophthalmology 2002 1.20
21 Cyclophosphamide for ocular inflammatory diseases. Ophthalmology 2009 1.14
22 Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006 1.13
23 Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol 2005 1.11
24 Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci 2012 1.07
25 The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm 2012 1.03
26 Risk of hypotony in noninfectious uveitis. Ophthalmology 2012 1.03
27 Risk of choroidal neovascularization among the uveitides. Am J Ophthalmol 2013 1.02
28 Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology 2013 1.02
29 Retinal vascular occlusion in patients infected with human immunodeficiency virus. Retina 2005 1.01
30 Hypopyon in patients with uveitis. Ophthalmology 2009 0.99
31 Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006 0.99
32 Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials. Clin Trials 2011 0.97
33 Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol 2004 0.97
34 Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseases Study. Ophthalmology 2012 0.97
35 Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis. Am J Ophthalmol 2003 0.97
36 Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology 2006 0.96
37 Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor 2009 0.95
38 Disparities in access to medical care for individuals with vision impairment. Ophthalmic Epidemiol 2009 0.94
39 Ocular immune reconstitution inflammatory syndromes. Curr Opin HIV AIDS 2008 0.94
40 Difluprednate 0.05% versus prednisolone acetate 1% for endogenous anterior uveitis: a phase III, multicenter, randomized study. Invest Ophthalmol Vis Sci 2014 0.92
41 Peripapillary choroidal neovascularization in pars planitis. J Ophthalmic Inflamm Infect 2013 0.92
42 Response of pediatric uveitis to tumor necrosis factor-α inhibitors. J Rheumatol 2013 0.90
43 Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm 2012 0.88
44 Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiol Drug Saf 2014 0.87
45 Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression. Am J Ophthalmol 2004 0.85
46 Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology 2015 0.85
47 Epidemiology of Behçet disease. Ocul Immunol Inflamm 2012 0.84
48 Diagnosis and treatment of microsporidial keratoconjunctivitis: literature review and case series. J Ophthalmic Inflamm Infect 2011 0.84
49 HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS 2002 0.83
50 The prevalence and causes of visual loss among HIV-infected individuals in Uganda. J Acquir Immune Defic Syndr 2010 0.82
51 Population-based prevalence of uveitis in Southern India. Br J Ophthalmol 2010 0.82
52 High-dose intravenous corticosteroids for ocular inflammatory diseases. Ocul Immunol Inflamm 2012 0.81
53 Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology 2012 0.81
54 Fundus image diagnostic agreement in uveitis utilizing free and open source software. Can J Ophthalmol 2013 0.81
55 Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis. Am J Ophthalmol 2003 0.81
56 The need for a revised approach to epidemiological monitoring of the prevalence of visual impairment. Ophthalmic Epidemiol 2011 0.80
57 Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocul Immunol Inflamm 2011 0.79
58 Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma. Am J Ophthalmol 2010 0.79
59 Risk of relapse in primary acute anterior uveitis. Ophthalmology 2011 0.78
60 Marginal structural models for comparing alternative treatment strategies in ophthalmology using observational data. Ophthalmic Epidemiol 2013 0.77
61 Methodologic rigor of clinical trials on surgical management of eyes with coexisting cataract and glaucoma. Ophthalmology 2002 0.75
62 Recurrent nodular scleritis preceding an adult TINU syndrome. Ocul Immunol Inflamm 2006 0.75
63 Cataract surgery in patients with uveitis. Int Ophthalmol Clin 2015 0.75